1-3 of 3
Michael S Magee
Close
Sort by
Journal Articles

Deploying an RNA-Based Gene Writer System and Lipid Nanoparticle (LNP) Delivery to Generate Functional Chimeric Antigen Receptor (CAR) T Cells with in Vitro and In Vivo Anti-Tumor Activity

Michael S Magee, Alberto De Iaco, Jason Rodriguez, James B. Rottman, Donghui Liu, Giulia Schiroli, Pooja Sabhachandani, Yu Cao, Rebecca Levy, Mohit Gupta, Michael T. Monte, Jane Wang, Bill Querbes, Cecilia Cotta-Ramusino, Madhusudan V Peshwa, Michael C Holmes
Journal: Blood
Blood (2023) 142 (Supplement 1): 2073.
https://doi.org/10.1182/blood-2023-184755
Published: 2023
Journal Articles

Knockout of CBLB Greatly Enhances Anti-Tumor Activity of CAR T Cells

Kathryn Hooper, PhD, Kyle Havens, PhD, Anne-Rachel Krostag, BS, Michael S Magee, PhD, Unja Martin, Ankit Gupta, PhD, Yegor Smurnyy, PhD, Lisa Pechilis, Amanda Rode, Andrew Chavkin, MS, Shannon Grande, PhD, Richard A. Morgan, PhD, Jordan Jarjour, PhD, Alexander Astrakhan, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 338.
https://doi.org/10.1182/blood-2018-99-119247
Published: 2018
Journal Articles

Gene Editing of TRAC Locus Utilizing Megatal Nucleases Increases Expression of Transgenic TCRs Delivered Via Lentiviral Vector-Mediated Gene Transfer

Michael S Magee, PhD, Iulia Diaconu, PhD, Mark Pogson, PhD, Ankit Gupta, PhD, Amy Jensen-Smith, PhD, Brian Collette, BS, Andrew Chavkin, MS, Eli Pasackow, BS, Aaron Edwards, MS, Kevin M. Friedman, Alexander Astrakhan, PhD, Michael T Certo, PhD, Jordan Jarjour, PhD, Richard A. Morgan, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1906.
https://doi.org/10.1182/blood.V130.Suppl_1.1906.1906
Published: 2017